S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

PCSA Processa Pharmaceuticals Inc

0.2293

-0.006 (-2.55%)

Last Updated: 13:08:47

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals Inc News

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
Tuesday 15 April 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 11 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 11 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 20 March 2025 (1 month ago) • Edgar (US Regulatory)

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Tuesday 18 March 2025 (1 month ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Tuesday 18 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 10 February 2025 (3 months ago) • Edgar (US Regulatory)

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
Friday 7 February 2025 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 30 January 2025 (3 months ago) • Edgar (US Regulatory)

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Thursday 30 January 2025 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (3 months ago) • Edgar (US Regulatory)

More Processa Pharmaceuticals Inc News Articles

ETFS 2x Daily Long Wheat

MTS EX-BANK OF ITALY BOT...

Xtrackers Treasuries Ult...

Fresenius Medical Care

Graniteshares 3xshort Al...

Kraneshares Msci China A...

Hsbc Msci Japan Climate ...

Graniteshares 1x Short F...

Tabula Us Enhanced Infla...

Australia SSA Bonds UCIT...

Fidelity Us Quality Inco...

WisdomTree Physical Gold...

Global X Genomics & Biot...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions